Kilpeläinen Group

Read more
91 - 93 out of 93Page size: 10
Sort by: 1st author
  1. Published

    A novel rare CUBN variant and three additional genes identified in Europeans with and without diabetes: results from an exome-wide association study of albuminuria

    Ahluwalia, T. S., Schulz, C-A., Waage, J., Skaaby, T., Sandholm, N., van Zuydam, N., Charmet, R., Bork-Jensen, J., Almgren, P., Thuesen, B. H., Bedin, M., Brandslund, I., Christensen, C. K., Linneberg, A., Ahlqvist, E., Groop, P-H., Hadjadj, S., Tregouet, D-A., Jorgensen, M. E., Grarup, N. & 9 others, Pedersen, Oluf Borbye, Simons, M., Groop, L., Orho-Melander, M., McCarthy, M. I., Melander, O., Rossing, Peter, Kilpeläinen, Tuomas O. & Hansen, Torben, 2019, In: Diabetologia. 62, 2, p. 292-305

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Editorial: Novel biomarkers for type 2 diabetes

    Ahluwalia, T. S., Kilpeläinen, Tuomas O., Singh, S. & Rossing, Peter, 1 Sep 2019, In: Frontiers in Endocrinology. 10, p. 1-3 3 p., 649.

    Research output: Contribution to journal › Editorial › Research › peer-review

  3. Published

    In vivo characterization of the ultrapotent monoacylglycerol lipase inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048)

    Aaltonen, N., Kedzierska, E., Orzelska-Górka, J., Lehtonen, M., Navia-Paldanius, D., Jakupovic, Hermina, Savinainen, J. R., Nevalainen, T., Laitinen, J. T., Parkkari, T. & Gynther, M., Oct 2016, In: Journal of Pharmacology and Experimental Therapeutics. 359, 1, p. 62-72 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...6 7 8 9 10 Next